ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,939Medicare Part D Prescriptions Filled, Including Refills

Rank: 85 out of 617

$486K Total Retail Price of All Prescriptions

Rank: 109 out of 617

300 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 300 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

23% of this provider’s 300 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 8,705 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 511 390 1 1
TRAMADOL HCL 427 376 2 15
OMEPRAZOLE 329 243 3 3
HYDROCODONE-ACETAMINOPHEN 326 252 S3 4 8
FUROSEMIDE 309 260 5 4
WARFARIN SODIUM 285 240 6 7
HYDROCHLOROTHIAZIDE 255 247 7 13
LISINOPRIL 236 213 8 5
METFORMIN HCL 221 156 9 9
DIVALPROEX SODIUM 187 121 10 111
AMLODIPINE BESYLATE 185 147 11 6
GLIMEPIRIDE 149 109 12 33
SPIRONOLACTONE 149 113 12 42
SIMVASTATIN 148 144 14 2
METOPROLOL SUCCINATE 118 89 15 12
GABAPENTIN 114 96 16 16
FENTANYL 112 103 S2 17 45
SERTRALINE HCL 112 94 17 20
CLONIDINE HCL 110 84 19 55
POTASSIUM CHLORIDE 110 100 19 10
POLYETHYLENE GLYCOL 3350 105 101 21 32
CITALOPRAM HBR 102 86 22 18
LOSARTAN POTASSIUM 100 96 23 22
VENLAFAXINE HCL ER 99 76 24 76
DONEPEZIL HCL 97 86 25 30
LANTUS 96 66 26 39
METOPROLOL TARTRATE 95 87 27 11
CARVEDILOL 92 84 28 19
ZOLPIDEM TARTRATE 89 74 29 23
MIRTAZAPINE 88 76 30 50
PREDNISONE 87 84 31 31
DIGOXIN 84 79 32 48
ESCITALOPRAM OXALATE 83 49 33 65
PRAVASTATIN SODIUM 81 67 34 21
TRICOR 81 36 34 83
MELOXICAM 75 56 36 24
BENAZEPRIL HCL 73 40 37 44
AZITHROMYCIN 70 62 38 70
TRIAMTERENE-HCTZ 69 69 39 47
ALLOPURINOL 67 48 40 27
METHYLPHENIDATE HCL 67 48 40 215
TAMSULOSIN HCL 66 66 42 26
DETROL LA 66 66 42 127
ADVAIR DISKUS 66 54 42 38
ENABLEX 62 35 45 229
LISINOPRIL-HYDROCHLOROTHIAZIDE 62 51 45 29
CARBIDOPA-LEVODOPA 61 61 47 69
ENALAPRIL MALEATE 60 60 48 34
SULFAMETHOXAZOLE-TRIMETHOPRIM 59 37 49 91
ATENOLOL 58 46 50 17
DILTIAZEM 24HR CD 55 55 51 117
PAROXETINE HCL 54 33 52 62
ATORVASTATIN CALCIUM 54 33 52 14
CYMBALTA 54 31 52 49
CEPHALEXIN 53 43 55 68
PANTOPRAZOLE SODIUM 53 51 55 37
NEXIUM 51 51 57 43
AMIODARONE HCL 50 50 58 129
RAMIPRIL 50 40 58 67
METOCLOPRAMIDE HCL 50 47 58 125
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 19, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.